Skip to main content
. 2015 Feb 18;64(5):573–583. doi: 10.1007/s00262-015-1657-9

Fig. 2.

Fig. 2

Immunohistochemistry of biopsy material for NKG2D and DNAM-1 ligands. Immunohistochemistry of NKG2D (MICA and ULBP1) and DNAM-1 (CD112 and CD155) ligands in biopsies of 8 ERMS patients was performed. A representative example (patient #5; Table 2) is shown for the ligands, which illustrate the heterogeneous staining patterns with correlations to the staining pattern of the tumor marker myogenin (MYF4)